TORONTO, May 8, 2018 /CNW/ - Eyecarrot Innovations Corp ("Eyecarrot" or the "Company") (TSX-V: EYC) (OTCQB: EYCCF) is pleasedto announce the appointment of Patricia Andrich as Educational Advisor to Eyecarrot's Binovi Platform in the development of a world class library for advanced strategies in reflex integration. The appointment of Mrs. Andrich
(Logo: https://mma.prnewswire.com/media/688290/Eyecarrot_Logo.jpg )
Quote from Dr. Leonard Press about her Appointment . "I am delighted that Patti Andrich has joined the Eyecarrot/Binovi family as an advisor. She brings a wealth of experience in education and clinical practice, teaming with her spouse Dr. Alex Andrich in a highly successful practice that revolves around vision development neuro-optometric rehabilitation. Her presentations on primitive reflexes are highly regarded in our field by vision therapists and optometrists, and I look forward to the contributions that she will make to the Binovi Platform."
About Patti Andrich MA, OTR/L, COVT , INPP
Patti Andrich is an occupational therapist known for her success in treating individuals with difficulties in visual-motor, visual-perceptual, auditory perception and vestibular functioning. Patti received her Master degree from The Ohio State University College of Education and her occupational therapy degree from the Cleveland State University Department of Health Sciences. Additionally, Patti holds certification in auditory processing using The Listening Program with Bone Conduction from Advanced Brain Technologies and is certified in INPP primitive reflex integration techniques; having studied in England under the direction of Sally Goddard at the Institute of Neurological Physiological Psychology (INPP). Patti is a certified vision therapist, member of The Optometric Extension Program as well as the College of Optometrists in Vision Development, the recipient of several honors and awards and has been a guest speaker for local, state, national and international conferences.
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
On behalf of the Board of DirectorsAdam CegielskiPresident | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at http://www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All